about
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to ...
Read More
31.04
-2.35
(-7.04%)
3.9M
XNAS Volume
High volume+loss today
XNAS 25 Feb, 2026 4:30 PM (EST)
CEO Retirement
Alkermes long-time CEO Richard Pops to retire, COO Blair Jackson to succeed effective August 1
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Alkermes PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..